TCIM
LUMO

TIAA CREF Investment Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

TIAA CREF Investment Management’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$109K Buy
6,296
+3
+0% +$45 ﹤0.01% 2953
2018
Q4 		$86K Hold
6,293
– – ﹤0.01% 2971
2018
Q3 		$135K Hold
6,293
– – ﹤0.01% 3021
2018
Q2 		$270K Sell
6,293
-9,775
-61% -$448K ﹤0.01% 2975
2018
Q1 		$1.05M Buy
16,068
+126
+0.8% +$8.93K ﹤0.01% 2420
2017
Q4 		$1.16M Sell
15,942
-2,549
-14% -$211K ﹤0.01% 2393
2017
Q3 		$1.69M Buy
18,491
+8,051
+77% +$617K ﹤0.01% 2255
2017
Q2 		$691K Sell
10,440
-9
-0.1% -$1.11K ﹤0.01% 2717
2017
Q1 		$2.27M Sell
10,449
-264
-2% -$37.7K ﹤0.01% 2060
2016
Q4 		$991K Buy
10,713
+1,545
+17% +$174K ﹤0.01% 2542
2016
Q3 		$1.24K Sell
9,168
-2,064
-18% -$205K ﹤0.01% 2427
2016
Q2 		$1.14M Buy
11,232
+171
+2% +$21.2K ﹤0.01% 2441
2016
Q1 		$1.81M Sell
11,061
-804
-7% -$163K ﹤0.01% 2127
2015
Q4 		$3.89M Buy
11,865
+4,256
+56% +$1.39M ﹤0.01% 1732
2015
Q3 		$2.45M Sell
7,609
-278
-4% -$122K ﹤0.01% 2021
2015
Q2 		$3.14M Buy
7,887
+189
+2% +$80.3K ﹤0.01% 2006
2015
Q1 		$3.79M Sell
7,698
-168
-2% -$65.1K ﹤0.01% 1824
2014
Q4 		$2.81M Sell
7,866
-447
-5% -$133K ﹤0.01% 2022
2014
Q3 		$1.6M Sell
8,313
-97
-1% -$21.3K ﹤0.01% 2369
2014
Q2 		$2.01M Buy
8,410
+1,119
+15% +$228K ﹤0.01% 2306
2014
Q1 		$1.86M Hold
7,291
– – ﹤0.01% 2280
2013
Q4 		$1.44M Sell
7,291
-245
-3% -$43.6K ﹤0.01% 2445
2013
Q3 		$1.27M Buy
7,536
+54
+0.7% +$8.69K ﹤0.01% 2475
2013
Q2 		$1.33M Buy
+7,482
New +$1.06M ﹤0.01% 2405

Other funds holding LUMO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

TIAA CREF Investment Management's LUMO Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Lumos Pharma, Inc. Common Stock (LUMO) stake by 0.05% in Q1 2019, buying an estimated $45 and bringing the position to 6,296 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #2953.

TIAA CREF Investment Management first reported a position in LUMO in Q2 2013 and has held it in 24 quarters since. The position peaked at $3.89M in Q4 2015. 82 funds tracked by Wall St. Rank hold LUMO as of Q1 2019.

  • TIAA CREF Investment Management held 6,296 shares of Lumos Pharma, Inc. Common Stock worth $109K as of Q1 2019.
  • TIAA CREF Investment Management bought 3 Lumos Pharma, Inc. Common Stock shares in Q1 2019, an estimated $45.
  • Lumos Pharma, Inc. Common Stock made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2953 holding.
  • TIAA CREF Investment Management first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Lumos Pharma, Inc. Common Stock position peaked at $3.89M in Q4 2015.
  • 82 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.